The Antitrust Review of the Americas 2017

United States: Healthcare

Perhaps unlike any other industry, the world is fast changing at the intersection between healthcare and competition law and the specific effects on transactions between and among healthcare providers and insurers in the United States today. Transactions are fast and furious, as is intervention by the United States’ antitrust authorities on the federal, state, and even local levels. Recent legislation, designed to streamline and make the delivery of healthcare more efficient, shows further interventions by the United States’ executive and legislative branches. Simply, the healthcare transactional world is ablaze.

Interested in becoming a GCR author? Please contact our co-publishing manager, Jordan Hunter.

Get in touch